Circulating Cathelicidin Antimicrobial Peptide LL-37 Levels in Mothers and Preterm and Term Newborn Infants.

被引：0
|
作者：
Dubicke, Aurelija [1 ]
Hell, Eva [1 ]
Fransson, Emma [1 ]
Ekman-Ordeberg, Gunvor [1 ]
Danielsson, Kristina Gemzell [1 ]
Marchini, Giovanna [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
REPRODUCTIVE SCIENCES | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
T-011
引用
收藏
页码：114A / 114A
页数：1
相关论文
共 50 条
  • [31] Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults
    Dixon B.M.
    Barker T.
    McKinnon T.
    Cuomo J.
    Frei B.
    Borregaard N.
    Gombart A.F.
    BMC Research Notes, 5 (1)
  • [32] Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents
    Tzitzilis, Athanasios
    Boura-Theodorou, Anastasia
    Michail, Vassilios
    Papadopoulos, Stylianos
    Krikorian, Dimitrios
    Lekka, Marilena E.
    Koukkou, Anna-Irini
    Sakarellos-Daitsiotis, Maria
    Panou-Pomonis, Eugenia
    JOURNAL OF PEPTIDE SCIENCE, 2020, 26 (07)
  • [33] Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides
    Martynowycz, Michael
    Rice, Amy
    Andreev, Konstantin
    Pavinatto, Thatyane M. Nobre
    Wereszczynski, Jeff
    Gidalevitz, David
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 45A - 45A
  • [34] Circulating cathelicidin LL-37 in adult patients with pulmonary infectious diseases
    Majewski, Karol
    Zelechowska, Paulina
    Brzezinska-Blaszczyk, Ewa
    CLINICAL AND INVESTIGATIVE MEDICINE, 2017, 40 (01): : E34 - E39
  • [35] LL-37, the only human member of the cathelicidin family of antimicrobial peptides
    Durr, Ulrich H. N.
    Sudheendra, U. S.
    Ramamoorthy, Ayyalusamy
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (09): : 1408 - 1425
  • [36] Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37
    Wang, Guangshun
    Narayana, Jayaram Lakshmaiah
    Mishra, Biswajit
    Zhang, Yingxia
    Wang, Fangyu
    Wang, Chunfeng
    Zarena, D.
    Lushnikova, Tamara
    Wang, Xiuqing
    ANTIMICROBIAL PEPTIDES: BASICS FOR CLINICAL APPLICATION, 2019, 1117 : 215 - 240
  • [37] The Human Cathelicidin LL-37, a Defensive Peptide Against Rotavirus Infection
    Zohreh Hosseini
    Mohammad Bagher Habibi Najafi
    Masoud Yavarmanesh
    Angila Ataei-Pirkooh
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 911 - 919
  • [38] Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease
    Kusaka, S.
    Nishida, A.
    Takahashi, K.
    Bamba, S.
    Yasui, H.
    Kawahara, M.
    Inatomi, O.
    Sugimoto, M.
    Andoh, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01): : 96 - 106
  • [39] The Human Cathelicidin LL-37, a Defensive Peptide Against Rotavirus Infection
    Hosseini, Zohreh
    Najafi, Mohammad Bagher Habibi
    Yavarmanesh, Masoud
    Ataei-Pirkooh, Angila
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (02) : 911 - 919
  • [40] In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2
    Alagarasu, K.
    Patil, P. S.
    Shil, P.
    Seervi, M.
    Kakade, M. B.
    Tillu, H.
    Salunke, A.
    PEPTIDES, 2017, 92 : 23 - 30
12345